APA (7th ed.) Citation

Noyan-Ashraf, M. H., Momen, M. A., Ban, K., Sadi, A., Zhou, Y., Riazi, A. M., . . . Drucker, D. J. (2009). GLP-1R Agonist Liraglutide Activates Cytoprotective Pathways and Improves Outcomes After Experimental Myocardial Infarction in Mice. Diabetes (New York, N.Y.), 58(4), 975-983. https://doi.org/10.2337/db08-1193

Chicago Style (17th ed.) Citation

Noyan-Ashraf, Mohammad Hossein, et al. "GLP-1R Agonist Liraglutide Activates Cytoprotective Pathways and Improves Outcomes After Experimental Myocardial Infarction in Mice." Diabetes (New York, N.Y.) 58, no. 4 (2009): 975-983. https://doi.org/10.2337/db08-1193.

MLA (9th ed.) Citation

Noyan-Ashraf, Mohammad Hossein, et al. "GLP-1R Agonist Liraglutide Activates Cytoprotective Pathways and Improves Outcomes After Experimental Myocardial Infarction in Mice." Diabetes (New York, N.Y.), vol. 58, no. 4, 2009, pp. 975-983, https://doi.org/10.2337/db08-1193.